SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-023121
Filing Date
2021-09-20
Accepted
2021-09-20 11:40:10
Documents
14
Period of Report
2021-09-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35403
2 ex99-1.htm EX-99.1 30746
3 image_001.jpg GRAPHIC 2928
  Complete submission text file 0001493152-21-023121.txt   250837

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ocx-20210920.xsd EX-101.SCH 3021
5 XBRL LABEL FILE ocx-20210920_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE ocx-20210920_pre.xml EX-101.PRE 22357
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3570
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 211262485
SIC: 2835 In Vitro & In Vivo Diagnostic Substances